Aligos Therapeutics (ALGS) Financials: Revenue & Earnings
ALGS$5.17+0.43 +9.07%
$32.28M
Market Cap
-0.68
P/E
12.80
Forward P/E
62
Score
Aligos Therapeutics (ALGS) Financials: Revenue & Earnings
ALGS price $5.17 +0.43 +9.07%
- Ticker
- ALGS
- Price
- $5.17
- Change
- +0.43 +9.07%
- Market cap ?
- $32.28M
- P/E ?
- -0.68
- Forward P/E ?
- 12.80
- Dividend yield ?
- 0.00%
- Beta ?
- 2.36
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
- Value
- 59
- Quality
- 28
- Growth
- 100
Stocklytics score rationale: value 59, quality 28, growth 100.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 4359000 | 13907000 | 15529000 | 3945000 | 2186000 |
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for significant unmet medical needs in both viral and liver diseases. Key candidates in its pipeline include ALG-010133, an s-antigen transport-inhibiting oligonucleotide polymer, which is currently undergoing Phase Ib clinical trials for chronic hepatitis B (CHB). Another asset for CHB, ALG-000184…
Fair value
ALGS fair value $9.40. Price $5.17. Price is 45% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 207.09K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 6.24M. Net debt -13.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -2.44 | — | 4.85M |
| 2026-08-06 | -0.14 | -1.09 | 27.78M | 24.68M |
| 2026-05-07 | -2.21 | -2.29 | 2.83M | 250.00K |
| 2026-03-05 | -1.91 | -2.49 | 169.00K | 440.00K |
| 2025-11-06 | -3.04 | -2.09 | 741.00K | 266.67K |
| 2025-08-06 | -1.53 | -2.35 | 965.00K | 433.33K |
| 2025-05-06 | -2.11 | -2.80 | 311.00K | 500.00K |
| 2025-03-10 | -13.08 | -2.63 | 629.00K | 433.33K |
| 2024-11-06 | -3.07 | -2.15 | 1.27M | 433.33K |
| 2024-08-06 | 0.75 | -4.00 | 1.06M | — |
| 2024-05-07 | -5.50 | -4.75 | 986.00K | — |
| 2024-03-12 | -5.50 | -6.75 | 2.68M | 1.60M |
| 2023-11-02 | -10.25 | -12.00 | 3.24M | 1.60M |
| 2023-08-03 | -10.75 | -12.50 | 6.89M | — |
| 2023-05-04 | -13.25 | -12.25 | 2.72M | 1.42M |
| 2023-03-09 | -12.75 | -12.25 | 3.54M | 1.72M |
| 2022-11-02 | -11.00 | -14.25 | 4.11M | 750.00K |
| 2022-08-04 | -0.47 | -16.25 | 3.69M | 4.80M |
| 2022-05-04 | -0.84 | -16.50 | 2.57M | 2.18M |
| 2022-03-10 | -0.89 | -0.83 | 367.00K | — |
| 2021-11-04 | -19.50 | -20.75 | 1.54M | 1.63M |
| 2021-08-05 | -19.75 | -20.25 | 1.54M | 1.54M |
| 2021-05-10 | -18.50 | -22.50 | 910.00K | 1.07M |
| 2021-03-23 | -1.09 | -0.82 | — | — |
| 2020-11-25 | -11.00 | -0.78 | 2.03M | — |
| 2020-10-19 | -0.95 | — | — | — |
| 2020-03-31 | -0.91 | — | — | — |
| 2019-12-31 | -0.83 | — | — | — |
| 2019-09-30 | -0.64 | — | — | — |
| 2019-06-30 | -0.46 | — | — | — |
| 2019-03-31 | -0.46 | — | — | — |
| 2018-06-30 | -0.16 | — | — | — |
| 2018-03-31 | -0.16 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Preston Heather | Buy | 5.86K | $5.50 | 32.23K |
| 2026-06-25 | Chavez Margarita | Buy | 5.86K | $5.50 | 32.23K |
| 2026-06-25 | Martell Bridget A | Buy | 5.86K | $5.50 | 32.23K |
| 2026-06-25 | Scopa James Paul | Buy | 5.86K | $5.50 | 32.23K |
| 2026-06-25 | Nuechterlein Carole | Buy | 5.86K | $5.50 | 32.23K |
| 2026-06-25 | Hirth Peter | Buy | 5.86K | $5.50 | 32.23K |
| 2026-03-09 | Symons Julian A. | Buy | 23.31K | $7.03 | 163.87K |
| 2026-03-09 | Aneja Nikhil | Buy | 9.45K | $7.03 | 66.43K |
| 2026-03-09 | Calhoun Lesley Ann | Buy | 37.48K | $7.03 | 263.52K |
| 2026-03-09 | BLATT LAWRENCE | Buy | 105.84K | $7.03 | 744.06K |
| 2026-01-29 | Aneja Nikhil | Other | 3.80K | $16.00 | 60.80K |
| 2026-01-29 | Aneja Nikhil | Other | 2.64K | $11.74 | 30.99K |
| 2026-01-29 | Aneja Nikhil | Other | 7.16K | $16.87 | 120.70K |
| 2026-01-29 | Aneja Nikhil | Other | 3.60K | $8.68 | 31.25K |
| 2025-07-16 | BLATT LAWRENCE | Buy | 179.80K | $8.68 | 1.56M |
| 2025-07-16 | Symons Julian A. | Buy | 16.00K | $8.68 | 138.88K |
| 2025-07-16 | Calhoun Lesley Ann | Buy | 40.19K | $8.68 | 348.81K |
| 2025-06-25 | Nuechterlein Carole | Buy | 5.86K | $7.63 | 44.71K |
| 2025-06-25 | Scopa James Paul | Buy | 5.86K | $7.63 | 44.71K |
| 2025-06-25 | Hirth Peter | Buy | 5.86K | $7.63 | 44.71K |
| 2025-06-25 | Preston Heather | Buy | 5.86K | $7.63 | 44.71K |
| 2025-06-25 | Chavez Margarita | Buy | 5.86K | $7.63 | 44.71K |
| 2025-06-25 | Martell Bridget A | Buy | 5.86K | $7.63 | 44.71K |
| 2025-02-28 | BLATT LAWRENCE | Buy | 140.10K | $16.87 | 2.36M |
| 2025-02-28 | Symons Julian A. | Buy | 21.69K | $16.87 | 365.96K |
| 2025-02-28 | Calhoun Lesley Ann | Buy | 47.27K | $16.87 | 797.46K |
| 2024-10-08 | Achneck Hardean | Buy | 75.00K | $7.32 | 549.00K |
| 2024-09-23 | Achneck Hardean | Other | 0 | — | — |
| 2024-09-04 | Calhoun Lesley Ann | Buy | 10.88K | $11.74 | 127.73K |
| 2024-09-04 | BLATT LAWRENCE | Buy | 33.92K | $11.74 | 398.22K |
| 2024-09-04 | Symons Julian A. | Buy | 10.88K | $11.74 | 127.73K |
| 2024-08-07 | Chavez Margarita | Buy | 120.00K | $0.55 | 66.00K |
| 2024-08-07 | Preston Heather | Buy | 120.00K | $0.55 | 66.00K |
| 2024-08-07 | Chavez Margarita | Other | 0 | — | — |
| 2024-08-07 | Preston Heather | Other | 0 | — | — |
| 2024-06-27 | Hirth Peter | Buy | 60.00K | $0.38 | 22.80K |
| 2024-06-27 | Nuechterlein Carole | Buy | 60.00K | $0.38 | 22.80K |
| 2024-06-27 | Scopa James Paul | Buy | 60.00K | $0.38 | 22.80K |
| 2024-06-27 | Martell Bridget A | Buy | 60.00K | $0.38 | 22.80K |
| 2024-03-01 | McClure Matthew W. | Buy | 72.00K | $1.13 | 81.36K |
| 2024-03-01 | Calhoun Lesley Ann | Buy | 308.94K | $1.13 | 349.10K |
| 2024-03-01 | Symons Julian A. | Buy | 72.00K | $1.13 | 81.36K |
| 2024-03-01 | BLATT LAWRENCE | Buy | 965.43K | $1.13 | 1.09M |
| 2024-02-28 | Hirth Peter | Buy | 4.41K | $0.96 | 4.23K |
| 2024-02-28 | Scopa James Paul | Buy | 8.82K | $0.96 | 8.47K |
| 2024-02-28 | McClure Matthew W. | Buy | 75.18K | $0.96 | 72.18K |
| 2024-02-28 | McClure Matthew W. | Buy | 65.71K | $0.96 | 63.08K |
| 2024-02-28 | McClure Matthew W. | Buy | 16.43K | $0.96 | 15.77K |
| 2024-02-28 | Calhoun Lesley Ann | Buy | 75.00K | $0.96 | 72.00K |
| 2024-02-28 | Calhoun Lesley Ann | Buy | 51.83K | $0.96 | 49.76K |
| 2024-02-28 | Calhoun Lesley Ann | Buy | 18.75K | $0.96 | 18.00K |
| 2024-02-28 | BLATT LAWRENCE | Buy | 231.00K | $0.96 | 221.76K |
| 2024-02-28 | BLATT LAWRENCE | Buy | 132.35K | $0.96 | 127.06K |
| 2024-02-28 | BLATT LAWRENCE | Buy | 57.75K | $0.96 | 55.44K |
| 2024-02-28 | Symons Julian A. | Buy | 75.00K | $0.96 | 72.00K |
| 2024-02-28 | Symons Julian A. | Buy | 58.82K | $0.96 | 56.47K |
| 2024-02-28 | Symons Julian A. | Buy | 18.75K | $0.96 | 18.00K |
| 2024-02-28 | Nielsen Jack | Buy | 4.41K | $0.96 | 4.23K |
| 2024-02-28 | Nuechterlein Carole | Buy | 4.41K | $0.96 | 4.23K |
| 2024-02-28 | Martell Bridget A | Buy | 8.82K | $0.96 | 8.47K |
| 2024-02-27 | Hirth Peter | Sell | 15.00K | $26.58 | 398.70K |
| 2024-02-27 | Scopa James Paul | Sell | 30.00K | $29.10 | 873.00K |
| 2024-02-27 | McClure Matthew W. | Sell | 23.00K | $3.06 | 70.38K |
| 2024-02-27 | McClure Matthew W. | Sell | 255.63K | $16.18 | 4.14M |
| 2024-02-27 | Calhoun Lesley Ann | Sell | 176.24K | $16.18 | 2.85M |
| 2024-02-27 | Calhoun Lesley Ann | Sell | 26.25K | $3.06 | 80.33K |
| 2024-02-27 | BLATT LAWRENCE | Sell | 450.00K | $16.18 | 7.28M |
| 2024-02-27 | BLATT LAWRENCE | Sell | 80.85K | $3.06 | 247.40K |
| 2024-02-27 | Symons Julian A. | Sell | 200.00K | $16.18 | 3.24M |
| 2024-02-27 | Symons Julian A. | Sell | 26.25K | $3.06 | 80.33K |
| 2024-02-27 | Nielsen Jack | Sell | 15.00K | $26.58 | 398.70K |
| 2024-02-27 | Nuechterlein Carole | Sell | 15.00K | $26.58 | 398.70K |
| 2024-02-27 | Martell Bridget A | Sell | 30.00K | $16.52 | 495.60K |
| 2023-10-25 | ROCHE HOLDING LTD | Other | 0 | — | — |
| 2023-10-25 | ROCHE HOLDING LTD | Other | 3.97M | $0.76 | 3.00M |
| 2023-10-25 | Nuechterlein Carole | Buy | 7.93M | $0.76 | 6.00M |
| 2023-10-25 | Nuechterlein Carole | Buy | 3.97M | $0.76 | 3.00M |
| 2023-10-25 | BLATT LAWRENCE | Buy | 610.28K | $0.76 | 461.86K |
| 2023-10-25 | BLATT LAWRENCE | Buy | 305.14K | $0.76 | 230.93K |
| 2023-10-25 | Scopa James Paul | Buy | 183.08K | $0.76 | 138.56K |
| 2023-10-25 | Scopa James Paul | Buy | 91.54K | $0.76 | 69.28K |
| 2023-09-08 | McClure Matthew W. | Buy | 48.00K | $0.84 | 40.32K |
| 2023-09-08 | Calhoun Lesley Ann | Buy | 48.00K | $0.84 | 40.32K |
| 2023-09-08 | Quan Lucinda Y. | Buy | 48.00K | $0.84 | 40.32K |
| 2023-09-08 | Symons Julian A. | Buy | 48.00K | $0.84 | 40.32K |
| 2023-09-08 | BLATT LAWRENCE | Buy | 150.00K | $0.84 | 126.00K |
| 2023-07-20 | Martell Bridget A | Buy | 20.00K | $1.00 | 20.00K |
| 2023-07-20 | Nielsen Jack | Buy | 20.00K | $1.00 | 20.00K |
| 2023-07-20 | Hirth Peter | Buy | 20.00K | $1.00 | 20.00K |
| 2023-07-20 | Scopa James Paul | Buy | 20.00K | $1.00 | 20.00K |
| 2023-07-20 | Nuechterlein Carole | Buy | 20.00K | $1.00 | 20.00K |
| 2023-03-15 | McClure Matthew W. | Buy | 75.00K | $1.34 | 100.50K |
| 2023-03-15 | Symons Julian A. | Buy | 78.75K | $1.34 | 105.53K |
| 2023-03-15 | Calhoun Lesley Ann | Buy | 78.75K | $1.34 | 105.53K |
| 2023-03-15 | Quan Lucinda Y. | Buy | 78.75K | $1.34 | 105.53K |
| 2023-03-15 | Beigelman Leonid | Buy | 169.50K | $1.34 | 227.13K |
| 2023-03-15 | BLATT LAWRENCE | Buy | 242.50K | $1.34 | 324.95K |
| 2022-07-07 | McClure Matthew W. | Buy | 46.00K | — | — |
| 2022-07-07 | Quan Lucinda Y. | Buy | 52.50K | — | — |
| 2022-07-07 | Quan Lucinda Y. | Buy | 52.50K | $1.41 | 74.03K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 31, holders -3 vs prior quarter. Ownership 21.98%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 444.11K | 0 | 0.00% | 2.56M |
| ALYESKA INVESTMENT GROUP, L.P. | 412.00K | 0 | 0.00% | 2.38M |
| SIO CAPITAL MANAGEMENT, LLC | 327.24K | 0 | 0.00% | 1.89M |
| MARSHALL WACE, LLP | 246.58K | -20.56K | -7.69% | 1.42M |
| WOODLINE PARTNERS LP | 177.36K | 0 | 0.00% | 1.02M |
| VANGUARD CAPITAL MANAGEMENT LLC | 175.54K | -2.72K | -1.53% | 1.01M |
| BAKER BROS. ADVISORS LP | 83.06K | 0 | 0.00% | 479.23K |
| HHLR ADVISORS, LTD. | 76.25K | 0 | 0.00% | 439.94K |
| D. E. SHAW & CO., INC. | 66.46K | 55.48K | +505.42% | 383.49K |
| UBS GROUP AG | 59.99K | 22.93K | +61.86% | 346.12K |
| GEODE CAPITAL MANAGEMENT, LLC | 47.17K | -2.80K | -5.61% | 272.32K |
| JANE STREET GROUP, LLC | 32.40K | 32.40K | New | 186.96K |
| BLACKROCK, INC. | 30.29K | 17.25K | +132.30% | 174.78K |
| VANGUARD FIDUCIARY TRUST CO | 28.61K | 175 | +0.62% | 165.09K |
| DIMENSIONAL FUND ADVISORS LP | 21.04K | 21.04K | New | 121.42K |
| VERITION FUND MANAGEMENT LLC | 18.89K | 0 | 0.00% | 108.98K |
| TREXQUANT INVESTMENT LP | 12.34K | 12.34K | New | 71.20K |
| RENAISSANCE TECHNOLOGIES LLC | 10.80K | -89.65K | -89.25% | 62.32K |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 10.00K | 0 | 0.00% | 57.70K |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 4.65K | 3.70K | +389.47% | 26.83K |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 2.67K | 0 | 0.00% | 15.43K |
| ROYAL BANK OF CANADA | 2.12K | 0 | 0.00% | 12.00K |
| CITIGROUP INC | 1.81K | 1.81K | New | 10.43K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 359 | 294 | +452.31% | 2.07K |
| JPMORGAN CHASE & CO | 344 | -330 | -48.96% | 1.87K |
Earnings and financials
Aligos Therapeutics, Inc. (ALGS) trades at $5.17, with a market cap of $32.28M and a trailing P/E of -0.68. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 4359000 | 13907000 | 15529000 | 3945000 | 2186000 |
Insights · Dividends · Forecast · Financials · Learn